
Sequel to IOM report on medical errors

The growth of pharmaceuticals bearing restrictions has the profession and pharmacists worried

Media coverage of OxyContin abuse is hurting patients who rely on the narcotic pain killer.

DRUG APPROVALS FOSR 2000 - Part 2

New patient privacy rules will wreak havoc when they take effect

A Philadelphia Medicaid carrier shifts pharmacy benefit management function in-house and works with a pharmacy network to cut drug costs. It achieves savings despite increasing fees to pharmacies

JCAHO's patient safety standards take effect in July. How will they affect hospitals?

State pharmacy boards are tackling the issue of lunch/rest breaks for pharmacists.

CE on R.Ph. workload and time management

FDA approves Cancidas for invasive aspergillosis

Employers let PBMs manage Rx benefit, not just cut costs and utilization, according to the latest Wyeth-Ayerst look at Rx benefit cost and design.

Table on Medicaid dispensing fees by state

A California pharmacy board task force tackles manpower issues and stirs controversy.

DRUG APPROVALS CE PART 1

Hospice and palliative care pharmacists push for specialty recognition

Elan's Myobloc and Allergan's Botox receive approval for cervical dystonia

A lawsuit alleges a Totowa, N.J. pharmacist's dispening error lead to the death of a cancer patient from an overdose of Lomustine.

Highlights of NACDS press conference

The Washington pharmacy board has prepared medication error reduction recommendations for the legislature.

Government agency issues report on R.Ph. shortage

Kaiser survey finds Americans endorse mandatory reporting of drug errors


"Stark geographic differences in the prevalence of care" are delayed by cost

Alvesco approved for asthma